The global Endovenous Laser Therapy Market was valued at USD 378.3 Million in 2021 and is expected to reach USD 811.0 Million by 2031, finds `Future Market Insights (FMI) in a recent market survey.
Endovenous Laser Therapy Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2021 | USD 378.3 Million |
| Market Value 2022 | USD 407.6 Million |
| Market Value 2031 | USD 811.0 Million |
| CAGR 2022 to 2031 | 7.9% |
| Key Players | The key players in AngioDynamics, Inc.; Syneron Medical Ltd.; Dornier MedTech GmbH; Alma Lasers Ltd.; Alna-Medical system GmbH; LSO Medical; Wontech Co., Ltd.; intros Medical Laser GmbH and Energist Ltd |
| Share of Top 5 Countries | 59.7% |
The growing prevalence of varicose veins and the availability of user-friendly devices are expected to be primary factors driving the endovenous laser therapy market over the forecast period.
In addition, more and more patients are shifting towards advanced laser therapy from traditional treatment options to avoid unwanted injuries and complications, which is supporting the growth of the endovenous laser therapy market.
Also, the global rise in the rate of obesity is expected to increase the demand for endovenous laser therapy devices, thus driving the global endovenous laser therapy market.
The endovenous laser therapy market holds a 3.8% revenue share of the USD 10 Billion laser therapy market in 2021. Therefore, the demand for laser systems is on the rise as many patients are adopting minimally invasive procedures such as laser therapy to avoid any further complications.
Moreover, the continuous launch of new and improved products and increasing investment in research and development by the manufacturers of endovenous laser therapy devices would lead to the growth of the global market over the forecast period.
For instance, in April 2021, Alma, unveiled the new Alma PrimeXTM platform today, during a worldwide LIVE launch event, which was broadcasted from its headquarters studio.
Driven by this, sales of endovenous laser therapy are expected to rise at a 7.9% CAGR through 2031.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 7.25% |
| H1, 2022 Projected | 7.83% |
| H1, 2022 Outlook | 7.53% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 30 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (+) 28 ↑ |
The comparative analysis and market growth rate of the global endovenous laser therapy market as studied by Future Market Insights’ will show a negative BPS growth in the H1-2022 outlook as compared to the H1-2022 projected period by 30 BPS.
The market is subject to changes as per macro and industry standards. Factors that affect the market dynamics are related to side effects and postoperative complications.
Moreover, the availability of alternative treatments such as traditional vein surgery affects the adoption of endovenous laser therapy. All these factors are responsible for the observed reduction in the BPS values.
However, a positive BPS growth is expected in H1-2022 over H1- 2021 duration with 28 Basis Point Share (BPS). The reasons for the surge in the market is due to high prevalence of varicose veins, the availability of user-friendly featured devices, and the adoption of minimally invasive devices.
Additionally, top players are constantly launching new and improved products and increasing funding in research and development to propel market growth.
Sales of endovenous laser therapy grew at a CAGR of 6.7% between 2016 and 2021.
The rapid increase in the number of patients suffering from varicose veins is one of the key factors anticipated to strengthen the demand and growth of the endovenous laser therapy market. Varicose veins are more common in female patients than in male patients.
In addition, rising cases of varicose veins because of the growing aging population is a common problem worldwide. Shifting towards an unhealthy lifestyle can as well lead to varicose veins.
Some other factors creating a positive impact on the market are the fast and effective procedures offered by endovenous laser therapy for the treatment of varicose veins over traditional vein surgery. The procedure needs only local anesthesia with minimal discomfort.
Also, the therapy has a high success rate. These factors increase the adoption of endovenous laser therapy which in turn leads to market growth.
In addition, the major manufacturers present in the global market are focusing on offering user-friendly equipment to end users for reducing the chances of manual errors. Devices with features such as an intuitive user interface with portable devices & lesser buttons, data storage, and faster procedure setup are being offered by manufacturers to attract a larger customer base.
This is anticipated to boost the adoption and demand for the endovenous laser therapy market.
Principal Consultant
The availability of alternative treatments and the side effects associated with endovenous laser therapy are the major factors anticipated to hamper the growth of the market.
Although endovenous laser therapy is a simple and safe way to treat varicose veins, the possibility of suffering from potential but rare side effects cannot be neglected.
The most common side effect of this treatment method is aching and bruising at the puncture site, temporary numbness in the leg, or pain or inflammation in the length of the vein treated which may persist for up to 2 weeks in some patients.
Also, besides endovenous laser therapy, there are many other medical procedures available to treat varicose veins which will restrain the growth of this market.
Treatment options such as sclerotherapy, high ligation, and vein stripping are being implemented to treat varicose veins across the globe. Although there are no oral or topical drugs of proven efficacy for venous disease, still many patients rely on drugs for the management and treatment of varicose veins.
These options reduce the adoption of endovenous laser therapy thus hindering market growth.
The COVID-19 pandemic was projected to have a major impact on the development of the studied market. The market observed a huge slowdown in its growth due to the spread of the Covid-19 pandemic worldwide.
Along with the effects of COVID-19 on public health, there was the subsequent effect of near? universal cancelation and disruption of surgical facilities, which had unprecedented effects on patients with surgical conditions and surgical services.
However, in the post-COVID-19 situation, the increasing cases of varicose veins were expected to drive the market. As recovery began in 2021, key players started to improve their positions through capacity utilization, production expansion, and collaborations with other players in 2021.
Also, hospitals and ambulatory surgical centers were focusing on maintaining covid norms in order to prevent infections while performing surgeries.
The USA accounted for nearly 90.5% of the North American endovenous laser therapy market in 2021. The growth can be attributed to the increasing number of cases of varicose veins.
For example, as per the American Vein and Lymphatic Society, about 40 million people suffer from varicose veins in 2019, in the USA Also, the increase in the prevalence of obesity and increasing FDA approvals are expected to drive the sales in the USA Furthermore, the technological advancement in laser therapy and favorable reimbursement scenario are some other factors responsible for the growth of the market.
Germany accounted for 19.8% of the Europe endovenous laser therapy market in Europe in 2021. The rising availability of technologically advanced equipment in European countries like Germany is expected to drive the sales of the market during the forecast period.
In Germany, most healthcare treatment is provided under the public health systems, and the government is deliberately providing subsidies for healthcare treatment. This is an additional factor leading to market growth in Germany. Moreover, increasing awareness regarding the treatment of varicose veins is expected to fuel the demand in Germany.
The endovenous laser therapy market in China was worth USD 18.5 Million in 2021.
The increase in the need for varicose veins treatment in China due to the growing number of people suffering from varicose veins is expected to lead to a rise in the utilization of endovenous laser systems in China, thus resulting in the growth of the market in China. In addition, rapid development in laser technology in the country with an increasing number of local players in China is leading to market development during the forecast period.
Demand for endovenous laser therapy in Japan is expected to rise at an impressive 7.0% CAGR over the forecast period.
The need for early treatment for varicose veins due to the rising geriatric population in Japan is expected to be the primary factor driving the market in the country. Moreover, increasing government initiatives to increase awareness regarding laser therapy is likely to support the growth of the market. An increasing number of product launches in the country will add to the development of the market.
India accounted for 25.3% of the endovenous laser therapy market in Asia Pacific in 2021. The demand for the market in India is due to the rise in the obese population in the country.
Obesity is one of the factors responsible for varicose veins. Unhealthy diet and urbanization of lifestyle lead to obesity. Thus, a rise in the obese population is likely to drive the market in India. In addition, developed infrastructure and increasing disposable income in India are some factors increasing the adoption of laser treatment in the country.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By product, the endovenous laser systems segment held the maximum share of 92.0% in 2021, expanding at a rapid rate during the forecast period.
The increase in demand for early treatment due to the rising number of varicose veins cases and the availability of technologically advanced products are primary factors responsible for the growth of the segment over the forecast period.
Moreover, an increase in Research and Development expenditure in several countries is leading to an increase in the number of product launches with advanced features which in turn is increasing the adoption of endovenous laser systems for the treatment of varicose veins.
Due to the increasing need for minimally invasive procedures and minimal discomfort from procedures, several patients are adopting laser therapy over traditional treatments, which is adding to segment growth.
By end user, the ambulatory surgical center's segment held the maximum share of 36.2% in 2021, expanding at a rapid rate during the forecast period due to the increasing adoption rate of endovenous laser therapy in ASCs as it is a minimally invasive procedure and is completed in approximately 30-45 minutes.
Furthermore, the continuous innovations in the medical industry are leading to more and more procedures being performed in an outpatient setting rather than in hospitals. In recent years, the number of ambulatory surgical centers has risen due to a rise in demand from the major players in surgical care. physicians, patients, and insurers.
In addition, over 50% of all outpatient surgeries were performed in ASCs (ambulatory surgery centers) in 2017, which is expected to rise by 6-7% as per the Ambulatory Surgery Center Association and ASCA Foundation. This is expected to lead to the development of the segment.
Companies operating in the endovenous laser therapy market are fragmented by nature, with a large number of global and local competitors. These players are involved in a number of strategic alliances.
The product launch, FD approval, and acquisition accelerate the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market. Some of the recent instances include:
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2031 |
| Historical Data Available for | 2016 to 2021 |
| Market Analysis | USD Million for Value and Volume in Units |
| Key Countries Covered | The USA, Canada, Germany, The UK, France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
| Key Segments Covered | Product, End User, and Region |
| Key Companies Profiled | AngioDynamics, Inc.; Syneron Medical Ltd.; Dornier MedTech GmbH; Alma Lasers Ltd.; Alna-Medical system GmbH; LSO Medical; Wontech Co., Ltd.; intros Medical Laser GmbH; Energist Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global endovenous laser therapy market is projected to reflect high demand in the forecast period with a CAGR of 7.9% owing to the growing caseload for varicose veins and the availability of user-friendly devices.
The sales of endovenous laser therapy in the market have grown at a CAGR of nearly 6.7% between 2016 and 2021. The increasing prevalence of obesity together with the growing geriatric population has boosted the demand for endovenous laser therapy.
North America currently holds the largest market share in endovenous laser therapy. North America held 42.7% of the global market share in the endovenous laser therapy market with the USA being the leading contributor with a market value of over USD 146.1 Million in 2021.
Endovenous laser therapy in China is likely to hold a share of 35.3% during the forecast period of the East Asian market for endovenous laser therapy. The increase in the need for varicose veins treatment in China due to the growing number of people suffering from varicose veins is expected to lead to rising in the utilization of endovenous laser systems in China, thus resulting in the growth of the market in China.
Availability of novel endovenous laser treatment system, rapid adoption of laser systems by clinics and increased expertise are key trends driving sales of Endovenous laser therapy market across the globe.
India’s endovenous laser therapy market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 8.2% CAGR during the forecast period. Japan's market is expected to exhibit healthy growth of 7.0% CAGR during the forecast period.
The USA, Japan, China, Canada, and Russia are the top 5 countries that are driving the demand for the endovenous laser therapy market.
Leading companies of endovenous laser therapy are AngioDynamics, Inc., Syneron Medical Ltd., Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medical System GmbH, LSO Medical, Wontech Co., Ltd., intros Medical Laser GmbH and Energist Ltd.
1. Executive Summary | Endovenous Laser Therapy Market 2. Market Overview 3. Key Market Trends 4. Market Context 5. Market Background 6. Global Market Demand (in Volume Units) Analysis 2016 to 2021 and Forecast, 2022 to 2031 7. Global Market - Pricing Analysis 8. Global Market Demand Value (US$ Million) Analysis 2016 to 2021 and Forecast, 2022 to 2031 9. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2031, By Product 9.1. Endovenous Laser Systems 9.2. Endovenous Laser Fibers 10. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2031, By End User 10.1. Hospitals 10.2. Ambulatory Surgical Centers 10.3. Specialized Clinics 11. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2031, By Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. South Asia 11.5. East Asia 11.6. Oceania 11.7. Middle East & Africa (MEA) 12. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2031 13. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2031 14. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2031 15. South Asia Market Analysis 2016 to 2021 and Forecast 2022 to 2031 16. East Asia Market Analysis 2016 to 2021 and Forecast 2022 to 2031 17. Oceania Market Analysis 2016 to 2021 and Forecast 2022 to 2031 18. Middle East and Africa Market Analysis 2016 to 2021 and Forecast 2022 to 2031 19. Country Level Market Analysis 2016 to 2021 and Forecast 2022 to 2031 20. Market Structure Analysis 21. Competition Analysis 21.1. AngioDynamics, Inc. 21.2. Syneron Medical Ltd. 21.3. Dornier MedTech GmbH 21.4. Alma Lasers Ltd. 21.5. Alna-Medical System GmbH 21.6. LSO Medical 21.7. Wontech Co., Ltd. 21.8. intros Medical Laser GmbH 21.9. Energist Ltd. 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Endovenous Laser Therapy Market
